Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.67 |
| ▸ | MEN1 | O00255 | 2/20 | 0.67 |
| ▸ | PKM | P14618 | 1/20 | 0.67 |
| ▸ | MAPT | P10636 | 13/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.52 |
| ▸ | ATM | Q13315 | 2/20 | 0.49 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8036315 | 0.92 | MEN1 (0.57) | KMT2AMEN1PKMMAPTMAPK1 | |
| SCHEMBL8034144 | 0.91 | MAPT (0.66) | KMT2AMEN1PKMMAPTMAPK1 | |
| SCHEMBL4540776 | 0.90 | MAPT (0.63) | KMT2AMEN1PKMMAPTMAPK1 | |
| SCHEMBL8035392 | 0.87 | PPARG (0.53) | KMT2AMEN1PKMMAPTMAPK1 | |
| SCHEMBL4536851 | 0.87 | MAPT (0.54) | KMT2AMEN1PKMMAPTMAPK1 | |
| SCHEMBL4536613 | 0.86 | MAPT (0.55) | KMT2AMEN1PKMMAPTMAPK1 | |
| SCHEMBL8041848 | 0.85 | MAPT (0.56) | KMT2AMEN1PKMMAPTMAPK1 | |
| SCHEMBL8034146 | 0.85 | PPARG (0.57) | KMT2AMEN1PKMMAPTMAPK1 | |
| SCHEMBL4540765 | 0.85 | MEN1 (0.52) | KMT2AMEN1PKMMAPT | |
| SCHEMBL8034331 | 0.85 | PPARG (0.57) | KMT2AMEN1PKMMAPTMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009083526-A1 | NOVEL COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 2009-07-09 | — | — | WO | disclosed |
| WO-2009083526-A1 | NOVEL COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 2009-07-09 | — | — | WO | disclosed |